How do you pay?

How to pay the least

Ask for the cash price

Retacrit

Retacrit is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for Retacrit’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

Retacrit, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from Retacrit’s maker. Ask the pharmacy for Retacrit’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Retacrit is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldNone sold yet

What it’s used for

What the FDA label says

RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for:

  • Treatment of anemia due to
    • Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.
    • Zidovudine in patients with Human Immunodeficiency Virus (HIV) infection.
    • The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
  • Reduction of allogeneic red blood cell (RBC) transfusions in patients undergoing elective, noncardiac, nonvascular surgery.

Limitations of Use

RETACRIT has not been shown to improve quality of life, fatigue, or patient well-being.

RETACRIT is not indicated for use:

  • In patients with cancer receiving hormonal agents, biologic products, or radiotherapy, unless also receiving concomitant myelosuppressive chemotherapy.
  • In patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure.
  • In patients with cancer receiving myelosuppressive chemotherapy in whom the anemia can be managed by transfusion.
  • In patients scheduled for surgery who are willing to donate autologous blood.
  • In patients undergoing cardiac or vascular surgery.
  • As a substitute for RBC transfusions in patients who require immediate correction of anemia.

Source: the FDA label for Retacrit (Pfizer Laboratories Div Pfizer Inc), June 22, 2025. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Retacrit’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.